In HNSCC model, the combination group had significantly higher population of CEA-expressing tumor reactive CD8+ T cells compared to the vehicle group (8.28 ± 2.67 and 3.02 ± 0.75, respectively, P < 0.05; Fig. 3D). The gene discussed is CEACAM5; the disease is head and neck squamous cell carcinoma.